Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community

Marie L. Misso, Eliza C. Tassone, Michael F. Costello, Anuja Dokras, Joop Laven, Lisa J. Moran, Helena J. Teede

Research output: Contribution to journalReview ArticleResearchpeer-review

2 Citations (Scopus)

Abstract

The evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) integrates the best available evidence with international, multidisciplinary clinical expertise and consumer preferences to provide health professionals, consumers, and policy makers with high-quality, comprehensive guidance about diagnosing and managing PCOS. Here, we outline the rigorous and systematic process, defined a priori and documented to be reproducible, to minimize bias and maintain transparency, in alignment with the Appraisal of Guidelines for Research and Evaluation (AGREE II) criteria and incorporating the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework that render this PCOS evidence-based guideline credible, trustworthy, reliable, and useable.

Original languageEnglish
Pages (from-to)28-34
Number of pages7
JournalSeminars in Reproductive Medicine
Volume36
Issue number1
DOIs
Publication statusPublished - Jan 2018

Keywords

  • AGREE II
  • evidence-based guidelines
  • GRADE
  • methodology
  • polycystic ovary syndrome

Cite this

Misso, Marie L. ; Tassone, Eliza C. ; Costello, Michael F. ; Dokras, Anuja ; Laven, Joop ; Moran, Lisa J. ; Teede, Helena J. / Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community. In: Seminars in Reproductive Medicine. 2018 ; Vol. 36, No. 1. pp. 28-34.
@article{0a863045a9594f9bbac7e0745fb6841f,
title = "Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community",
abstract = "The evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) integrates the best available evidence with international, multidisciplinary clinical expertise and consumer preferences to provide health professionals, consumers, and policy makers with high-quality, comprehensive guidance about diagnosing and managing PCOS. Here, we outline the rigorous and systematic process, defined a priori and documented to be reproducible, to minimize bias and maintain transparency, in alignment with the Appraisal of Guidelines for Research and Evaluation (AGREE II) criteria and incorporating the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework that render this PCOS evidence-based guideline credible, trustworthy, reliable, and useable.",
keywords = "AGREE II, evidence-based guidelines, GRADE, methodology, polycystic ovary syndrome",
author = "Misso, {Marie L.} and Tassone, {Eliza C.} and Costello, {Michael F.} and Anuja Dokras and Joop Laven and Moran, {Lisa J.} and Teede, {Helena J.}",
year = "2018",
month = "1",
doi = "10.1055/s-0038-1667312",
language = "English",
volume = "36",
pages = "28--34",
journal = "Seminars in Reproductive Medicine",
issn = "1526-8004",
publisher = "Thieme Medical Publishers",
number = "1",

}

Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community. / Misso, Marie L.; Tassone, Eliza C.; Costello, Michael F.; Dokras, Anuja; Laven, Joop; Moran, Lisa J.; Teede, Helena J.

In: Seminars in Reproductive Medicine, Vol. 36, No. 1, 01.2018, p. 28-34.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community

AU - Misso, Marie L.

AU - Tassone, Eliza C.

AU - Costello, Michael F.

AU - Dokras, Anuja

AU - Laven, Joop

AU - Moran, Lisa J.

AU - Teede, Helena J.

PY - 2018/1

Y1 - 2018/1

N2 - The evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) integrates the best available evidence with international, multidisciplinary clinical expertise and consumer preferences to provide health professionals, consumers, and policy makers with high-quality, comprehensive guidance about diagnosing and managing PCOS. Here, we outline the rigorous and systematic process, defined a priori and documented to be reproducible, to minimize bias and maintain transparency, in alignment with the Appraisal of Guidelines for Research and Evaluation (AGREE II) criteria and incorporating the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework that render this PCOS evidence-based guideline credible, trustworthy, reliable, and useable.

AB - The evidence-based guideline for the assessment and management of polycystic ovary syndrome (PCOS) integrates the best available evidence with international, multidisciplinary clinical expertise and consumer preferences to provide health professionals, consumers, and policy makers with high-quality, comprehensive guidance about diagnosing and managing PCOS. Here, we outline the rigorous and systematic process, defined a priori and documented to be reproducible, to minimize bias and maintain transparency, in alignment with the Appraisal of Guidelines for Research and Evaluation (AGREE II) criteria and incorporating the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework that render this PCOS evidence-based guideline credible, trustworthy, reliable, and useable.

KW - AGREE II

KW - evidence-based guidelines

KW - GRADE

KW - methodology

KW - polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=85053280854&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1667312

DO - 10.1055/s-0038-1667312

M3 - Review Article

VL - 36

SP - 28

EP - 34

JO - Seminars in Reproductive Medicine

JF - Seminars in Reproductive Medicine

SN - 1526-8004

IS - 1

ER -